Maladie du charbon

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.

U.S. contracts for dry formulation of anthrax vaccine Read more:

A dry formulation for an anthrax vaccine is to be developed by a Maryland-based bio-pharmaceutical company under a U.S. government contract.
A dry formulation of Emergent BioSolutions Inc.'s NuThrax vaccine will increase its stability in ambient light and higher temperatures and eliminate the need for cold chain during shipping and storage.
The five-year contract, worth as much as $29 million, was issued by the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health.

Lost Small Pox Vials and Anthrax Mishaps

Last week the US Centres for Disease Control and Prevention announced that 6 small pox vials had been discovered on the 1st of July during the clearing out of an old laboratory at the Nationality Institute of Health’s (NIH) Bethesda campus, Maryland.

Public health: Joint purchasing of vaccines and medicines becomes a reality in the EU

Today, the Commission approved a Joint Procurement Agreement, which will enable all EU countries to procure pandemic vaccines and other medical countermeasures as a group, rather than individually.

US, 26 countries launch effort to fight outbreaks

The U.S. and 26 other countries began a new effort Thursday to prevent and fight outbreaks of dangerous infectious diseases before they spread around the globe.

U.S. health officials called the Global Health Security Agenda a priority because too many countries lack the health infrastructure necessary to spot a new infection rapidly and sound the alarm before it has time to gain a foothold and even spread into other countries.


Why Global Health Security Is Imperative

When he opened the box, André Berro was wearing surgical gloves, mask, and eye protection—routine protocol for a CDC quarantine public health officer, but this was not a routine package. A U.S. Customs scan of the airmail package that arrived at the San Francisco airport from the Philippines showed an outline of what looked like several human skulls.


U.S. gathers vaccine researchers to talk bioterrorism threat Q fever

While anthrax, smallpox and other "category A" bioterrorism threats dominate the collective public consciousness, a larger pool of lower-priority agents are also a danger. Q fever falls into this second tier, but the U.S. government is still sufficiently concerned to gather researchers to talk vaccine development.

Read the rest of the article here.



'Body on a chip' uses 3D printed organs to test vaccines

Miniature human organs developed with a modified 3D printer are being used to test new vaccines in a lab in the US.

The "body on a chip" project replicates human cells to print structures which mimic the functions of the heart, liver, lung and blood vessels. The organs are then placed on a microchip and connected with a blood substitute, allowing scientists to closely monitor specific treatments.


Michigan-made BioThrax remains only anthrax vaccine

Ten years ago, the nation's only licensed anthrax vaccine looked to be on the way out, plagued by concerns over its side effects, cost and a dosing schedule some thought too long to be effective in a bioterror attack.


7 new Antharx patients spotted in Sirajganj

In its latest bout, at least seven people including four women and a 10-year-old have been confirmed to have been infected with the bacterium in a village of Sirajganj’s Shahjadpur upazilla.

The bacterium remains a perennial problem in Bangladesh. In 2010 it took a heavy toll on Bangladesh's export-oriented leather industry.

Director of the government’s disease monitoring arm, IEDCR, Prof Mahmudur Rahman told they had confirmation of seven new patients identified on Wednesday and Thursday.

They were under treatment, he said.